SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetards Regulatory News (PEG)

Share Price Information for Petards (PEG)

Share Price is delayed by 15 minutes
Get Live Data
9.50    0.00 (0.00%)
Bid:
9.00
Ask:
10.00
Spread: 1.00 (11.111%)
Market Cap: £5.77m
PEG Live PriceLast checked at - London Stock Exchange

Intraday Petards Share Chart

Trading Statement

12 Jan 2018 07:00

RNS Number : 6685B
Petards Group PLC
12 January 2018
 

12 January 2018

 

 

PETARDS GROUP PLC

 ("Petards" or the "Group")

 

Trading Update

 

 

Petards, the AIM quoted developer of advanced security and surveillance systems, is pleased to provide an update on trading following the end of its financial year on 31 December 2017.

 

The Group's profit before tax for the year ended 31 December 2017 is expected to be above market expectations due to the positive net effect of exceptional items arising in the year. The Group expects to report 2017 revenues to be up year on year to £15.6 million. However, some delays in programmes to develop additional software functionality for eyeTrain systems has resulted in approximately £1 million of revenues being deferred into 2018. These relate to scheduled deliveries of both software and equipment and accordingly profit before tax from trading operations will be lower than previously expected.

 

Set against this, the 2017 results include two exceptional items. First, the Group has received and accepted an offer to settle a historic matter, unrelated to the current trading activities of the Group, which arose over ten years ago. Under the settlement the Group will receive a total of £702,000 in cash comprising an amount of £362,000 plus compensatory interest of £340,000. The Board considers this to be a very satisfactory outcome. The terms of the settlement preclude the Group from providing further details.

 

The second exceptional item is also unrelated to the current trading activities of the Group. The Board has decided that any future activities that the Group may undertake in the US will not be conducted through its present US subsidiary which has been dormant for several years. In accordance with International Accounting Standards, the £211,000 deficit on the Group's currency translation reserve will be reclassified from equity to income and shown as an expense. The reclassification has no impact on the Group's net assets or cash.

 

Raschid Abdullah, Chairman of Petards Group plc said:

 

"It was pleasing that in December we completed both the full conversion of the Group's £1,480,000 outstanding loan notes into Petards ordinary shares and have subsequently received the settlement of £702,000. As a result, the Group's balance sheet has been substantially strengthened with the removal of the loan note liability that was due for redemption in September 2018 and its cash resources have been increased this week following receipt of the £702,000.

 

While it is disappointing that delays in the development programmes for new eyeTrain products has deferred some revenues into 2018, the Group continues to trade profitably and enters 2018 with an order book of £18 million. Over £12 million of this is scheduled for delivery in the coming year and the Board remains confident of the Group's future prospects."

 

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

Contacts:

 

 

Petards Group plc

www.petards.com

 

Raschid Abdullah, Chairman

Mb: 07768 905 004

 

 

 

 

WH Ireland Limited, Nomad and Joint Broker

www.whirelandcb.com

 

Mike Coe / Ed Allsopp

Tel: 0117 945 3470

 

 

 

 

Hybridan LLP, Joint Broker

www.hybridan.com

Claire Louise Noyce

 

Tel: 020 3764 2341

claire.noyce@hybridan.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDLAILLIT
Date   Source Headline
2nd Nov 20177:00 amRNSHolding(s) in Company
12th Sep 20177:00 amRNSHalf-year Report
26th Jul 20177:00 amRNSGrant of Share Options
4th Jul 20177:00 amRNSContract wins
23rd Jun 20179:35 amRNSBlock listing Interim Review
26th May 20179:20 amRNSDirector/PDMR Shareholding
23rd May 20171:49 pmRNSContract Win
18th May 20175:08 pmRNSDirector/PDMR Shareholding
16th May 20173:50 pmRNSDirector/PDMR Shareholding
16th May 201712:05 pmRNSExercise of options and Director/PDMR Shareholding
11th May 20177:00 amRNSExercise of options and Director/PDMR Shareholding
26th Apr 20171:15 pmRNSResult of AGM
26th Apr 20177:00 amRNSAGM Statement
21st Apr 20179:00 amRNSHolding(s) in Company
7th Apr 20172:39 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSDirector/PDMR Shareholding
30th Mar 20174:45 pmRNSDirector/PDMR Shareholding
29th Mar 20177:00 amRNSContract Win
27th Mar 20177:40 amRNSPosting of Accounts and Notice of AGM
17th Mar 20177:00 amRNSHolding(s) in Company
14th Mar 20177:00 amRNSFinal Results
4th Jan 20177:00 amRNSHolding(s) in Company
23rd Dec 201610:31 amRNSBlock listing Interim Review
22nd Dec 201612:00 pmRNSContract
12th Dec 20167:00 amRNSContract win
31st Oct 20167:00 amRNSContract Win
10th Oct 20167:00 amRNSContract Win
28th Sep 20167:00 amRNSHolding(s) in Company
12th Sep 20164:17 pmRNSDirector/PDMR Shareholding
9th Sep 20167:00 amRNSPDMR Dealing
7th Sep 20167:00 amRNSHalf-year Report
16th Aug 20167:00 amRNSContract award
25th Jul 20167:00 amRNSContract win
23rd Jun 20167:00 amRNSBlock listing Interim Review
11th May 20162:15 pmRNSHolding(s) in Company
15th Apr 20167:00 amRNSResult of AGM
14th Apr 20167:05 amRNSAGM Statement
14th Apr 20167:00 amRNSAcquisition of QRO Solutions Limited
22nd Mar 20167:00 amRNSPosting of Annual Report and Notice of AGM
16th Mar 201611:00 amRNSHolding(s) in Company
15th Mar 20167:00 amRNSFinal Results
3rd Mar 20168:45 amRNSContract Award
6th Jan 20167:00 amRNSDirectorate Change
31st Dec 201510:30 amRNSChange of Registered Office
23rd Dec 20157:00 amRNSBlocklisting Interim Review
17th Dec 20157:00 amRNSCompletion of Capital Reduction
11th Nov 201512:46 pmRNSResult of GM
23rd Oct 201512:30 pmRNSProposed capital reduction and notice of GM
12th Oct 20157:00 amRNSContract win
25th Sep 20159:27 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.